Brief: Emcure Pharmaceuticals Says Emcutix And Wiqo Sign Exclusive Licensing Partnership
01/04/2025 08:40
April 1 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS: EMCUTIX AND WIQO SIGN EXCLUSIVE LICENSING PARTNERSHIP EMCUTIX SECURES EXCLUSIVE RIGHTS FOR PRX-PLUS IN INDIAN MARKET Further company coverage: EMCU.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees